ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Weakness
Clear All
Filter by Field of Research
Medical Physiology not elsewhere classified (4)
Cell Physiology (3)
Medical biotechnology diagnostics (incl. biosensors) (3)
Neurology and Neuromuscular Diseases (3)
Intensive Care (2)
Neurology And Neuromuscular Diseases (2)
Rehabilitation And Therapy: Occupational And Physical (2)
Biochemistry And Cell Biology Not Elsewhere Classified (1)
Biologically Active Molecules (1)
Biomechanics (1)
Clinical Nursing: Tertiary (Rehabilitative) (1)
Medical biochemistry - carbohydrates (1)
Paediatrics (1)
Physiotherapy (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (26)
Filter by Status
Closed (26)
Filter by Scheme
NHMRC Project Grants (12)
Project Grants (7)
Early Career Fellowships (5)
Career Development Fellowships (1)
Postgraduate Scholarships (1)
Filter by Country
Search did not return any results.
Filter by Australian State/Territory
Search did not return any results.
  • Researchers (0)
  • Funded Activities (26)
  • Organisations (0)
  • Funded Activity

    An Early Intervention To Prevent Muscle Weakness In Intensive Care

    Funder
    National Health and Medical Research Council
    Funding Amount
    $82,607.00
    Summary
    Patients commonly suffer from a debilitating and globally pronounced weakness post intensive care admission. The causes and ways to prevent this weakness are not fully understood. This study will investigate the benefits of early exercise involving electrical stimulation of the leg muscles during in-bed cycling and will compare changes in muscle size and strength compared to usual care. We will also examine why muscles become weak so quickly, to help target future treatments to prevent weakness.
    More information
    Funded Activity

    Demystifying The Burden Of Intensive Care Survivorship - Understanding Muscle Wasting And Falls

    Funder
    National Health and Medical Research Council
    Funding Amount
    $314,644.00
    Summary
    For individuals who survive an intensive care admission, there is no prevention or cure for the development of intensive care acquired weakness. This project aims to examine the impact of muscle loss and weakness on balance, falls and the ability to walk. These outcomes are important to patients as it directly impacts on the ability to undertake day-to-day activities, their confidence and return to work. Results will be used to inform clinical practice and improvement in patient care.
    More information
    Funded Activity

    Rescuing The Dystrophin-glycoprotein Complex To Protect Muscles From Wasting Conditions

    Funder
    National Health and Medical Research Council
    Funding Amount
    $833,340.00
    Summary
    Existing medical strategies to counteract severe muscle wasting disorders are compromised because of dysfunctional signalling around a cluster of proteins called the dystrophin-glycoprotein complex (DGC) located at the muscle membrane. To address this significant unmet medical need, this proposal investigates novel approaches to retain or restore DGC integrity at the muscle membrane with the goals of preserving and protecting muscles during serious wasting conditions.
    More information
    Funded Activity

    The Role Of The Systemic Milieu In Preventing Motor Unit Remodelling And Loss During Ageing

    Funder
    National Health and Medical Research Council
    Summary
    Motor unit remodeling and loss contributes to the decline in muscle mass, strength and quality of life in our aging population. Recent data shows that exposing aged mice to 'blood-borne factors' from the circulation of a young mouse can reverse the age-associated deficits in motor unit structure and function. A better understanding of the factors controlling these anti-aging effects will be vital for finding new compounds to reverse the aging process and improve quality of life.
    More information
    Funded Activity

    Novel Therapies To Treat Muscle Wasting In Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $589,371.00
    Summary
    Cancer cachexia is a devastating disease characterised by muscle wasting, weakness and fatigue. It impairs patient quality of life and accounts for >20% of cancer-related deaths. This project will identify factors responsible for cancer cachexia and develop new strategies to alleviate wasting and weakness in cancer patients, to improve their quality of life and reduce mortality.
    More information
    Funded Activity

    Establishing STARS As A Therapeutic Target To Reduce Muscle Wasting And Improve Muscle Function

    Funder
    National Health and Medical Research Council
    Funding Amount
    $446,189.00
    Summary
    Muscle wasting occurs rapidly with disuse after injuries occurring at work, during sport, with chronic disease and in road accidents. It is also a consequence of ageing. Muscle wasting and reduced muscle function places considerable financial strain on our health care system. We aim to use gene therapy and pharmacological interventions to increase the levels of a protein called STARS. We hypothesize that STARS will reduce disuse-induced muscle wasting, increase recovery and improve function.
    More information
    Funded Activity

    Therapeutic Potential Of Modulating Heat Shock Protein Expression For Muscle Wasting Disorder

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,172,146.00
    Summary
    Heat shock proteins help stressed proteins fold back to their original conformation and restore function. In a discovery published in Nature we identified induction of heat shock protein 72 (Hsp72) as a novel approach for muscular dystrophy and other conditions where there is inflammation and muscle weakness. This proposal will investigate whether Hsp72 induction is similarly effective in tackling the muscle wasting and weakness in conditions like ageing and frailty and in muscle injury.
    More information
    Funded Activity

    Targeted Strength Training To Improve Functional Walking Capacity Of Adolescents And Young Adults With Cerebral Palsy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $263,449.00
    Summary
    Cerebral palsy is the most common cause of disability in children. Caused by damage to the brain in early childhood cerebral palsy leads to muscle weakness and difficulties in walking. There is no cure for cerebral palsy, but we can help the weak muscles . The purpose of this trial is to establish that exercises to strengthen the weakest muscles will help the walking ability of teenagers and young adults with cerebral palsy, as they make the transition to independence and adulthood.
    More information
    Funded Activity

    Determining The Pathomechanics Of Muscle Weakness In Older Individuals With Toe Deformities In Order To Develop Evidence-based Intervention Strategies To Restore Foot Function

    Funder
    National Health and Medical Research Council
    Funding Amount
    $316,251.00
    Summary
    Hallux valgus and lesser toe deformities are highly prevalent foot problems in older people that can cause foot disfigurement, physical discomfort, and increase the risk of falling. This study will investigate how toe muscle weakness is affected by these toe deformities as the basis upon which to develop interventions that can restore foot function in older individuals, in order to reduce falls risk, foot pain and, in turn, improve independence and quality of life throughout ageing.
    More information
    Funded Activity

    Intensive Care Management And Quality Of Survival Of Acute Respiratory Distress Syndrome

    Funder
    National Health and Medical Research Council
    Funding Amount
    $307,946.00
    Summary
    Acute respiratory distress syndrome (ARDS) is a severe inflammatory condition of the lungs that complicates many critical illnesses and is associated with high mortality and morbidity. Although intensive care admission and mechanical ventilation provide life-saving support during ARDS, they can lead to poor long term outcome. The aim of this program is to compare the clinical efficiency of new strategies in ICU to that of current standard care and to improve the quality of survival of patients w .... Acute respiratory distress syndrome (ARDS) is a severe inflammatory condition of the lungs that complicates many critical illnesses and is associated with high mortality and morbidity. Although intensive care admission and mechanical ventilation provide life-saving support during ARDS, they can lead to poor long term outcome. The aim of this program is to compare the clinical efficiency of new strategies in ICU to that of current standard care and to improve the quality of survival of patients with ARDS.
    Read more Read less
    More information

    Showing 1-10 of 26 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback